EMPLOYMENT AGREEMENTEmployment Agreement • March 31st, 2008 • PharmaNet Development Group Inc • Services-commercial physical & biological research • New Jersey
This EMPLOYMENT AGREEMENT (the “Agreement”) entered into as of January 10, 2007 (the “Effective Date”), by and between Robin C. Sheldrick (the “Executive”) and PharmaNet Development Group, Inc., a Delaware corporation (the “Company”).
SEVERANCE AGREEMENT AND GENERAL RELEASESeverance Agreement and General Release • March 31st, 2008 • PharmaNet Development Group Inc • Services-commercial physical & biological research • New Jersey
THIS SEVERANCE AGREEMENT AND GENERAL RELEASE (“Release Agreement”) is executed by David Natan (the “Executive”) pursuant to Section 6 of the Employment Agreement dated as of January 10, 2007 by and between PharmaNet Development Group, Inc., a Delaware corporation (the “Company”) and the Executive (the “Employment Agreement”).
SIXTH AMENDMENTSixth Amendment • March 31st, 2008 • PharmaNet Development Group Inc • Services-commercial physical & biological research • New York
SIXTH AMENDMENT (this “Amendment”), dated as of March 11th, 2008 to the AMENDED AND RESTATED CREDIT AGREEMENT, dated as of June 14, 2005 (as amended, supplemented or otherwise modified from time to time, the “Credit Agreement”), among PHARMANET DEVELOPMENT GROUP, INC. (f/k/a SFBC INTERNATIONAL, INC.)(the “Borrower”), the Subsidiary Guarantors party thereto (the “Subsidiary Guarantors”), the Lenders and other agents from time to time party thereto and UBS AG, STAMFORD BRANCH, as Administrative Agent and Collateral Agent.
PHARMANET DEVELOPMENT GROUP, INC. RESTRICTED STOCK UNIT ISSUANCE AGREEMENTStock Option Agreement • March 31st, 2008 • PharmaNet Development Group Inc • Services-commercial physical & biological research • Delaware
